CSL BEHRING GENE THERAPY, INC.

CYTEGRITY

Biomanufacturing for others, namely, manufacturing of pharmaceuticals and of viral vectors and gene therapy vectors;Scientific, pharmaceutical and medical research and development; biological research; laboratory services in connection with viral vectors and gene therapy vectors;

CYTEGRITY

Cell lines for medical purposes; Cells for medical or clinical use; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating cancer, tumors, genetic diseases, immunodeficiency conditions, stem cell transplantation, and transplant medicine; Cell lines for medical purposes, namely, cell therapy; Cell lines for medical purposes, namely, immunotherapy; Cell lines for medical purposes, namely, for use as therapeutics to repair, replace or preserve cells and tissues; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating genetically engineered tissues and for treating transplant conditions; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating viral and infectious diseases; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders;Cell lines for scientific and research use; Cells for scientific, laboratory or medical research; Biological preparations, namely, viral vectors and gene vectors for scientific, laboratory or medical research;

GENECAPS

Non-viral vectors in the form of nanoscale matrices, namely, pharmaceutical preparations for the delivery of therapeutic agents for the treatment or prevention of diseases affecting the immune system or hematologic system; Non-viral vectors, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals;GENE CAPS;

SELECT+

Chemoselective agents for gene therapy, namely for the treatment or prevention of diseases affecting the immune system or hematologic system;